Results 81 to 90 of about 3,650 (207)

Thyroid function patterns in Ghanaian women using depo-medroxyprogesterone acetate

open access: yesCurrent Medicine Research and Practice
Background: The main hormonal contraceptives of choice for most women in Ghana are progestin-only injectables, norethisterone enanthate and depot-medroxyprogesterone acetate (DMPA).
John Cletus Osei   +7 more
doaj   +1 more source

Patient satisfaction of depot medroxyprogesterone acetate (dmpa-sc) injection as contraceptive

open access: yes, 2010
Patient satisfaction of depot medroxyprogesterone acetate (dmpa-sc) injection as ...
M Afzal (13515244)   +2 more
core  

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

open access: yes, 1996
Our purpose was to evaluate the efficacy and safety of depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol in the long-term treatment of pelvic pain in women with ...
O. De Giorgi   +5 more
core   +1 more source

Lessons from the scale-up of provider-administered and self-injection of DMPA-SC in Nigeria: a landscape assessment

open access: yesBMC Women's Health
Background Nigeria is the seventh-most populous country in the world. Its high fertility rate and unmet need for family planning contribute to the increasing population size.
Adewole A. Adefalu   +9 more
doaj   +1 more source

GnRH Analog Combined with Depot Medroxyprogesterone Acetate in the Management of Endometrial Hyperplasia: A Prospective Randomized Clinical Study

open access: yes, 2016
OBJECTIVE: To compare the effectiveness of combined treatment of depot medroxyprogesterone acetate (MPA) with gonadotropin-releasing hormone (GnRH) analog and depot MPA alone in the management of simple endometrial hyperplasia without atypia among heavy ...
Karabacak, NEŞE   +4 more
core  

Depot Medroxyprogesterone Acetate (Depo-Provlera) as a Contrac·eptive Preparation

open access: yes, 2017
Experience with depot medroxyprogesterone acetate as a contraceptive preparation in 7 335 patients for a total of 38 714 months over a 3-year period is described.
Bloch, Basil
core  

Gonadotropin-releasing hormone agonist and depot medroxyprogesterone acetate following uterine artery embolization in the management of uterine arteriovenous malformation

open access: yes, 2013
A young woman presenting with recurrent episodes of uterine bleeding due to an extensive uterine arteriovenous malformation was treated with two sessions of uterine artery embolization.
Sivasambu, Gayatri Devi   +7 more
core   +1 more source

Sexual function of depot medroxyprogesterone acetate users

open access: yes, 2018
{"references": ["Ahmadi, Z et al. (2011). Sexual satisfaction and its related factors in primigravidas. Iran J Nurs. 24(71):54-62.", "Clayton, AH. (2003). Sexual function and dysfunction in women. Psychiatr Clin North Am. 26(3):673-82.", "DeLamater, J & Karraker, A. (2009). Sexual functioning in older adults. Current Psychiatry Reports.
Indrayani   +5 more
openaire   +2 more sources

Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate

open access: yes, 2015
Apparently, depot-medroxyprogesterone acetate (DMPA) increases a woman's risk of acquiring HIV. The objective of this study was to test whether the vaginal mucosal thickness and Langerhans cell counts were significantly different in long-term DMPA users ...
Fernandes, Arlete   +6 more
core   +1 more source

Injectable contraceptive continuation and user experiences in Punjab, Pakistan: a non-randomized prospective cohort study protocol

open access: yesBMC Women's Health
Background Evidence from multiple pilots and post-introduction scale-up initiatives have demonstrated that self-administered subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) has potential to improve contraceptive continuation rates and expand ...
Hannah Tappis   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy